Among these proteins, expression levels of Col4A5, GPC1 and HAS2 increased progressively with metastatic potential or tumor size in cell and animal experiments, respectively (Figs. 1, 2, Supplementary Figure 1, 3). The gene discussed is GPC1; the disease is neoplasm.